1. Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute,
85, 365–376.
2. Osoba, D., Aaronson, N. K., Zee, B., et al. (1997). Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. Quality of Life Research,
6, 103–108.
3. Aaronson, N. K., Cull, A., Kaasa, S., & Sprangers, M. A. G. (1996). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: An update. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 179–189). Philadelphia: Lippincott-Raven Publishers.
4. Fayers, P. M., Aaronson, N., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A., et al. (2001). EORTC QLQ-C30 scoring manual (3rd ed.). Brussels: European Organization for Research and Treatment of Cancer.
5. Raykov, T. (2004). Behavioral scale reliability and measurement invariance evaluation using latent variable modeling. Behavior Therapy,
35(2), 299–331.